rs6151428
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_000487.6(ARSA):c.1493G>T(p.Arg498Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000213 in 1,594,594 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R498H) has been classified as Benign.
Frequency
Consequence
NM_000487.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARSA | NM_000487.6 | c.1493G>T | p.Arg498Leu | missense_variant | 8/8 | ENST00000216124.10 | NP_000478.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARSA | ENST00000216124.10 | c.1493G>T | p.Arg498Leu | missense_variant | 8/8 | 1 | NM_000487.6 | ENSP00000216124 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152216Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000689 AC: 15AN: 217596Hom.: 0 AF XY: 0.0000584 AC XY: 7AN XY: 119784
GnomAD4 exome AF: 0.0000187 AC: 27AN: 1442260Hom.: 0 Cov.: 32 AF XY: 0.0000126 AC XY: 9AN XY: 715882
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152334Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74504
ClinVar
Submissions by phenotype
Metachromatic leukodystrophy Uncertain:2Benign:1Other:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
not provided, no classification provided | in vitro | Gelb Laboratory, University of Washington | - | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Feb 13, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 10, 2022 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | May 29, 2024 | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at